Impel Pharmaceuticals Inc.

IMPLNASDAQHealthcare

$0.04

$-0.02(-27.27%)

Market Cap$956000

P/E Ratio—

52W High$4.2

52W Low$0.0212

Avg Volume1.0M

Open$0.05

Beta1.17

Overview

Impel Pharmaceuticals Inc.（IMPL）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · IMPL · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Impel Pharmaceuticals Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

IMPL 季度内部人买卖趋势

IMPL 内幕交易卖出 · IMPL 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

1.3M668K0

2021 Q3

2021 Q4

2022 Q1

2022 Q2

2022 Q4

2023 Q1

2023 Q2

2023 Q4

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

近期内幕交易记录

IMPL 高管卖出股份 · IMPL 董事内幕交易 · SEC Form 4申报

显示最近 35 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Dec 15, 2023	Vivo Capital VIII, LLC 10 percent owner	Sale	87,934	$0.29	$26K	2,447,181	Form 4
Dec 18, 2023	Vivo Capital VIII, LLC 10 percent owner	Sale	209,029	$0.11	$23K	2,238,152	Form 4
Dec 19, 2023	Vivo Capital VIII, LLC 10 percent owner	Sale	208,657	$0.08	$17K	2,029,495	Form 4
Dec 15, 2023	Vivo Capital VIII, LLC 10 percent owner	Sale	12,066	$0.29	$3K	337,608	Form 4
Dec 18, 2023	Vivo Capital VIII, LLC 10 percent owner	Sale	28,682	$0.11	$3K	308,926	Form 4
Dec 19, 2023	Vivo Capital VIII, LLC 10 percent owner	Sale	28,632	$0.08	$2K	280,294	Form 4
Dec 31, 2022	Leaman John Harold Chief Fin. & Business Officer	Option	10,571	—	—	10,571	Form 4
Dec 31, 2022	Leaman John Harold Chief Fin. & Business Officer	Other	3,627	$3.75	$14K	6,944	Form 4
Mar 29, 2022	SHREWSBURY STEPHEN B Chief Medical Officer	Option	24,606	$1.97	$48K	97,990	Form 4
Dec 22, 2021	Hoekman John Chief Scientific Officer	Option	20,000	$1.64	$33K	128,221	Form 4
Nov 19, 2021	NELSON TIMOTHY S Director	Purchase	10,000	$10.76	$108K	10,000	Form 4
Sep 21, 2021	SHREWSBURY STEPHEN B Chief Medical Officer	Option	53,954	$2.95	$159K	73,384	Form 4
Sep 21, 2021	SHREWSBURY STEPHEN B Chief Medical Officer	Option	4,650	$2.46	$11K	19,430	Form 4
Sep 21, 2021	SHREWSBURY STEPHEN B Chief Medical Officer	Option	14,780	$1.97	$29K	14,780	Form 4
Aug 18, 2021	ADAMS ADRIAN COB, CEO and President · Director	Purchase	600	$15.89	$10K	20,000	Form 4
Aug 18, 2021	ADAMS ADRIAN COB, CEO and President · Director	Purchase	2,197	$14.91	$33K	19,400	Form 4
Aug 18, 2021	ADAMS ADRIAN COB, CEO and President · Director	Purchase	17,203	$13.81	$238K	17,203	Form 4
Apr 27, 2021	Vivo Capital VIII, LLC 10 percent owner	Purchase	505,620	$15.00	$7.58M⚡	2,535,115	Form 4
Apr 27, 2021	Vivo Capital VIII, LLC 10 percent owner	Other	89,145	$13.50	$1.20M⚡	2,029,495	Form 4
Apr 27, 2021	Vivo Capital VIII, LLC 10 percent owner	Other	315,328	—	—	1,940,350	Form 4
Apr 27, 2021	Vivo Capital VIII, LLC 10 percent owner	Other	440,119	—	—	1,625,022	Form 4
Apr 27, 2021	Vivo Capital VIII, LLC 10 percent owner	Other	474,713	—	—	1,184,903	Form 4
Apr 27, 2021	Vivo Capital VIII, LLC 10 percent owner	Other	710,190	—	—	710,190	Form 4
Apr 27, 2021	Vivo Capital VIII, LLC 10 percent owner	Purchase	69,380	$15.00	$1.04M⚡	349,674	Form 4
Apr 27, 2021	Vivo Capital VIII, LLC 10 percent owner	Other	12,311	$13.50	$166K	280,294	Form 4

Vivo Capital VIII, LLC

10 percent owner

Sale

日期

Dec 15

股数

87,934

均价

$0.29

总金额

$26K

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Sale

日期

Dec 18

股数

209,029

均价

$0.11

总金额

$23K

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Sale

日期

Dec 19

股数

208,657

均价

$0.08

总金额

$17K

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Sale

日期

Dec 15

股数

12,066

均价

$0.29

总金额

$3K

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Sale

日期

Dec 18

股数

28,682

均价

$0.11

总金额

$3K

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Sale

日期

Dec 19

股数

28,632

均价

$0.08

总金额

$2K

View Form 4 on SEC.gov

Leaman John Harold

Chief Fin. & Business Officer

Option

日期

Dec 31

股数

10,571

均价

—

总金额

—

View Form 4 on SEC.gov

Leaman John Harold

Chief Fin. & Business Officer

Other

日期

Dec 31

股数

3,627

均价

$3.75

总金额

$14K

View Form 4 on SEC.gov

SHREWSBURY STEPHEN B

Chief Medical Officer

Option

日期

Mar 29

股数

24,606

均价

$1.97

总金额

$48K

View Form 4 on SEC.gov

Hoekman John

Chief Scientific Officer

Option

日期

Dec 22

股数

20,000

均价

$1.64

总金额

$33K

View Form 4 on SEC.gov

NELSON TIMOTHY S

Director

Purchase

日期

Nov 19

股数

10,000

均价

$10.76

总金额

$108K

View Form 4 on SEC.gov

SHREWSBURY STEPHEN B

Chief Medical Officer

Option

日期

Sep 21

股数

53,954

均价

$2.95

总金额

$159K

View Form 4 on SEC.gov

SHREWSBURY STEPHEN B

Chief Medical Officer

Option

日期

Sep 21

股数

4,650

均价

$2.46

总金额

$11K

View Form 4 on SEC.gov

SHREWSBURY STEPHEN B

Chief Medical Officer

Option

日期

Sep 21

股数

14,780

均价

$1.97

总金额

$29K

View Form 4 on SEC.gov

ADAMS ADRIAN

COB, CEO and President · Director

Purchase

日期

Aug 18

股数

600

均价

$15.89

总金额

$10K

View Form 4 on SEC.gov

ADAMS ADRIAN

COB, CEO and President · Director

Purchase

日期

Aug 18

股数

2,197

均价

$14.91

总金额

$33K

View Form 4 on SEC.gov

ADAMS ADRIAN

COB, CEO and President · Director

Purchase

日期

Aug 18

股数

17,203

均价

$13.81

总金额

$238K

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Purchase

日期

Apr 27

股数

505,620

均价

$15.00

总金额

$7.58M ⚡

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Other

日期

Apr 27

股数

89,145

均价

$13.50

总金额

$1.20M ⚡

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Other

日期

Apr 27

股数

315,328

均价

—

总金额

—

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Other

日期

Apr 27

股数

440,119

均价

—

总金额

—

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Other

日期

Apr 27

股数

474,713

均价

—

总金额

—

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Other

日期

Apr 27

股数

710,190

均价

—

总金额

—

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Purchase

日期

Apr 27

股数

69,380

均价

$15.00

总金额

$1.04M ⚡

View Form 4 on SEC.gov

Vivo Capital VIII, LLC

10 percent owner

Other

日期

Apr 27

股数

12,311

均价

$13.50

总金额

$166K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 IMPL 内幕交易

IMPL 内幕交易

Impel Pharmaceuticals Inc.（IMPL）内幕交易数据来源于公司内部人（包括IMPL）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。IMPL内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Impel Pharmaceuticals Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

IMPL 内幕交易 · 5个问题

Impel Pharmaceuticals Inc.（IMPL）的内部人包括高管和董事，如IMPL等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

IMPL 董事内幕交易IMPL 内部人名单Impel Pharmaceuticals Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026